Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
Rhea-AI Summary
Coherus BioSciences (CHRS) will release its first quarter 2022 financial results on May 5, 2022, after market close. Following the announcement, management will host a conference call at 5 p.m. ET to discuss the results and provide a business update. Interested parties can access the call by dialing (844) 452-6826 for U.S. and Canadian callers or (765) 507-2587 internationally. A replay will be available on the company's website for 30 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CHRS declined 4.14%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter 2022 financial results will be released after the close of the United States financial markets on Thursday, May 5th, 2022. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
After releasing first quarter 2022 financial results, the Company will post them on the Coherus website at https://investors.coherus.com.
Conference Call Information
When: Thursday, May 5th, 2022, starting at 5 p.m. ET
Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)
Conference ID: 4142969
Webcast: https://investors.coherus.com/upcoming-events
Please dial-in 15 minutes early to ensure a timely connection to the call. A replay of the webcast will be archived on the Coherus website for 30 days.
Coherus Contact Information:
McDavid Stilwell
Chief Financial Officer
Coherus BioSciences, Inc.
IR@coherus.com